28Mar2016 When Does it Make Sense to Acqui-Hire in Biotech? /Luke Timmerman/1/All, People, The Edge28 Mar 2016 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.